This NIH program supports researchers in developing small-molecule neurotherapeutics by providing funding, expert guidance, and industry resources to advance drug candidates toward clinical testing.
Supporting biologic-based drug discovery and development for nervous system disorders through preclinical research, Phase I trials, and collaboration with NIH consultants and CROs.
NIH supports development, testing, and clinical feasibility studies of therapeutic and diagnostic devices for nervous or neuromuscular disorders through milestone-driven cooperative agreements.
NIH supports discovery of in vivo chemical probes for novel brain targets, with applicants expected to have validated starting compounds and bioassays; clinical trials are not allowed.
This grant will fund partnerships to expand the use and integration of BRAIN Initiative neurotechnologies at institutions with limited NIH research funding, supporting two-way knowledge transfer and training.
This grant will fund the development and validation of innovative tools and technologies to study and manipulate specific cells and circuits in the brain, aiming to advance our understanding of brain structure and function.